1.Prof.Li Zhihui gave an oral presentation on the theme of"CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma"2.Prof.Zhao Defeng made a poster display with the theme of"Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia"3.Prof.Pan Jing made a poster display with the theme of"CAR-T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma:A Retrospective Study"4.The international multi-center research results"Project Evolve,Evaluation of Lineage Switch(LS),an International Initiative:Preliminary Results Reveal Dismal Outcomes in Patients with LS"were published by Director Pan Jing.5.Dr.Lin Yuehui was selected as the abstract of the paper on the topic"The Efficacy and Safety of Olverembatinib Combined with …

1.A study co-conducted by Director Liu Shuangyou and Director Yu Xinjian was selected as an oral report at the annual meeting,"CD58 Could Be as a Leukemic Marker in Relapsed/Refractory B-ALL Patients after Multiline Therapies".2.Head Nurse Zhang Na made a poster display with the theme of"Effects of BMI,Albumin and NRS 2002 Changes on Prognosis in Patients with Hematological Malignancies during CAR-T Treatment".3.Dr.Tan Yue made a poster display with the theme of"Efficacy and Safety of Donor-Derived CD7 CAR-T Cells for r/r T-Cell Acute Lymphoblastic Leukemia/Lymphoma:Interim Analysis from a Phase 2 Trial".4.Dr.Zheng Peihao made a poster display with the theme of"Exploring the Efficiency and Survival of CAR-T-Cell Therapy in DLBCL Patients with MYC and/or TP53 Abnormalities".5.Prof.Li Zhihui made a poster display with the theme of"Profiles of Germline Predisposition Gene Variants in Hematologic Disorders and Its Impact on Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation".6…

1.Prof.Hu Kai gave an oral presentation on the theme of"Aoto Hematopoietic Stem Cell transplantation Combined with Another Target Humanized CAR-T Cells for Refractory/Relapsed B-cell Non-Hodgkin Lymphoma after Failure of Murinized CD19 CAR-T Therapy".2.Prof.Liu Ying gave an oral presentation on the theme of"Efficacy and Safety of Sequential Different B Cell Antigen-Targeted CAR-T-Cell Therapy for Pediatric Refractory/Relapsed Burkitt Lymphoma with Secondary Central Nervous System Involvement".3.Prof.Yang Fan gave an oral presentation on the theme of"Allogeneic Hematopoietic Stem Cell Transplantation with Conditioning Including Donor Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma and Multiple Myeloma".4.Dr.Wang Shan made a poster display with the theme of"ALK inhibitor plus Vinblasitine for refractory/relapsed pediatric ALK+anaplastic large cell lymphoma:A prospective,one-arm,open-label real-world study".5.Prof.Li Zhihui made a poster display with the theme of…

1.Dr.Li Zhihui gave an oral presentation on the theme of"Influence of Inherited and Acquired Hematological and Immunological Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies".2.Dr.Song Yanzhi made a poster display with the theme of"Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation of AML in CR and MDS—a Systematic Review and Meta-Analysis of Randomized Controlled Trials".3.Dr.Yang Fan made a poster display with the theme of"Interleukin-7 Receptor Gene Heterozygous Mutations in Recipients Significantly Increase Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation"and"Daratumumab and Venetoclax-Containing Regimens in the Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies".4.Prof.Yu Xinjian made a poster display with the theme of"The Quick Antigen Identification By Tissue Flow Cytome…

1.Prof.Liu Shuangyou gave an oral presentation on the theme of"Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia".2.Dr.Pan Jing gave an oral presentation on the theme of"Association of Genetic Factors with Long-Term Outcome in Refractory r/r B-ALL Patients after CAR-T-Cell Therapy".3.Dr.Li Zhihui made a poster display with the theme of"Potential Influence of Hematological or Immunological Hereditary Predisposition Genes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies".